Fredun Pharmaceuticals Peer Comparison

Fredun Pharmaceuticals Ltd. lags significantly behind its peers in key financial metrics such as revenue growth, profitability, and efficiency. While it has no debt, its lack of growth and profitability highlights it as a potential underperformer in the sector. In contrast, companies like Mankind Pharma and Dr. Reddy's Laboratories showcase strong growth and profitability, making them sector leaders.

• • Fredun Pharmaceuticals has zero revenue growth and profitability metrics (EPS, ROE, etc.).
• • Mankind Pharma leads in revenue growth and profitability metrics, while Sun Pharma has high returns but poor growth.
• • Cipla and Dr. Reddy's show a balanced approach with good growth and profitability, offering strong sector performance.

• • Mankind Pharma Ltd.: Highest revenue growth (YoY: 18.12%) and strong profitability (ROE: 23.15%)
• • Dr. Reddy's Laboratories Ltd.: Consistently strong profitability (ROE: 21.76%) and reasonable valuation metrics (PE: 15.50)